Rezulin
Rezulin is a Warner-Lambert drug for Type II diabetes, which lowers the blood sugar by helping the body better respond to insulin. Rezulin was taken off the market on March 21, 2000, after 63 reported cases of death due to liver failure were reported by the LA Times. Rezulin has been banned in England since December, 1997.